Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 21, 2005; 11(11): 1623-1628
Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1623
Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1623
Visick | 2 (mo, %) | 12 (mo, %) | ||||
I Symptoms-free | 22 (71) | 27(87) | ||||
II Mild symptoms | 8 (26) | - Dysphagia | 6/8 | 3 (10) | - Dysphagia | 2/3 |
- Bloating | 3/8 | - Bloating | 2/3 | |||
- Epigastric pain | 2/8 | Heartburn | 1/3 | |||
III Can be treated with medication or with dilation | 1 (3) | - Dysphagia | 1 (3) | - Dysphagia | ||
- Heartburn | - Heartburn | |||||
- Belching | - Belching | |||||
IV Reoperation needed | - | - |
- Citation: Altorjay A, Juhasz A, Kellner V, Sohar G, Fekete M, Sohar I. Metabolic changes in the lower esophageal sphincter influencing the result of anti-reflux surgical interventions in chronic gastroesophageal reflux disease. World J Gastroenterol 2005; 11(11): 1623-1628
- URL: https://www.wjgnet.com/1007-9327/full/v11/i11/1623.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i11.1623